Final rule published
Global Benchmark for Efficient Drug Pricing (GLOBE) Model
Record date · Oct 2, 2026
What this means
- Status
- Final rule published
- What happened
- This final rule implements the Global Benchmark for Efficient Drug Pricing Model (GLOBE Model), a new mandatory Medicare payment model under section 1115A of the Social Security Act. The GLOBE Model will test whether a payment model that uses an alternative method for calculating Medicare Part B drug inflation rebate amounts for certain separately payable Medicare Part B drugs and biological products reduces costs for Original Medicare (OM) beneficiaries a…
- What to check next
- The published rule gives Nov 30, 2026 as its effective date. Check the official docket for later changes.
About this record
This final rule implements the Global Benchmark for Efficient Drug Pricing Model (GLOBE Model), a new mandatory Medicare payment model under section 1115A of the Social Security Act. The GLOBE Model will test whether a payment model that uses an alternative method for calculating Medicare Part B drug inflation rebate amounts for certain separately payable Medicare Part B drugs and biological products reduces costs for Original Medicare (OM) beneficiaries and the Medicare program while preserving quality of care. The term OM has the same meaning as Medicare fee-for-service and the traditional Medicare program.
Record details
- Federal Register document
- 2026-20281
- Stated effective date
- 2026-11-30
- Docket
- CMS-5545-F
Sources and related records
Source checked .